<ol class="cite-this-references"><li id="reference-A190681">Redin GS: Antibacterial activity in mice of minocycline, a new tetracycline. Antimicrob Agents Chemother (Bethesda). 1966;6:371-6. [<a href="/articles/A190681" target="_blank">Article</a>] </li><li id="reference-A190696">Nelis HJ, De Leenheer AP: Metabolism of minocycline in humans. Drug Metab Dispos. 1982 Mar-Apr;10(2):142-6. [<a href="/articles/A190696" target="_blank">Article</a>] </li><li id="reference-A190699">Welling PG, Shaw WR, Uman SJ, Tse FL, Craig WA: Pharmacokinetics of minocycline in renal failure. Antimicrob Agents Chemother. 1975 Nov;8(5):532-7. doi: 10.1128/aac.8.5.532. [<a href="/articles/A190699" target="_blank">Article</a>] </li><li id="reference-A190702">Simon C, Malerczyk V, Preuss I, Schmidt K, Grahmann H: [Activity in vitro and pharmacokinetics of minocycline (author's transl)]. Arzneimittelforschung. 1976 Apr;26(4):556-60. [<a href="/articles/A190702" target="_blank">Article</a>] </li><li id="reference-A190708">Saivin S, Houin G: Clinical pharmacokinetics of doxycycline and minocycline. Clin Pharmacokinet. 1988 Dec;15(6):355-66. doi: 10.2165/00003088-198815060-00001. [<a href="/articles/A190708" target="_blank">Article</a>] </li><li id="reference-A190714">Zhou J, Tran BT, Tam VH: The complexity of minocycline serum protein binding. J Antimicrob Chemother. 2017 Jun 1;72(6):1632-1634. doi: 10.1093/jac/dkx039. [<a href="/articles/A190714" target="_blank">Article</a>] </li><li id="reference-A190723">Garrido-Mesa N, Zarzuelo A, Galvez J: Minocycline: far beyond an antibiotic. Br J Pharmacol. 2013 May;169(2):337-52. doi: 10.1111/bph.12139. [<a href="/articles/A190723" target="_blank">Article</a>] </li><li id="reference-A19429">Chopra I, Roberts M: Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev. 2001 Jun;65(2):232-60 ; second page, table of contents. [<a href="/articles/A19429" target="_blank">Article</a>] </li><li id="reference-L11695">FDA Approved Drug Products: Minocin Minocycline Oral Capsules (Discontinued) [<a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&amp;ApplNo=050315" target="_blank">Link</a>] </li><li id="reference-L11701">FDA Approved Drug Products: Ximino Minocycline Oral Extended Release Capsules [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/201922s002lbl.pdf" target="_blank">Link</a>] </li><li id="reference-L11704">FDA Approved Drug Products: Solodyn Minocycline Oral Extended Release Tablets [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/050808s023lbl.pdf" target="_blank">Link</a>] </li><li id="reference-L11707">FDA Approved Drug Products: Minocycline Oral Capsules [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/anda/99/65-005_Minocycline%20Hydrochloride_prntlbl.pdf" target="_blank">Link</a>] </li><li id="reference-L11710">FDA Approved Drug Products: Minocin Minocycline Oral Pellet-Filled Capsules [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/050649s027lbl.pdf" target="_blank">Link</a>] </li><li id="reference-L11713">FDA Approved Drug Products: Minocin Minocycline Powder for Intravenous Injection [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/050444s049lbl.pdf" target="_blank">Link</a>] </li><li id="reference-L11716">FDA Approved Drug Products: Arestin Minocycline Subgingival Microspheres [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/050781s020lbl.pdf" target="_blank">Link</a>] </li><li id="reference-L11719">FDA Approved Drug Products: Amzeeq Minocycline Topical Foam [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212379s000lbl.pdf" target="_blank">Link</a>] </li><li id="reference-L11722">Cayman Chemical: Minocycline MSDS [<a href="https://www.caymanchem.com/msdss/14454m.pdf" target="_blank">Link</a>] </li></ol>